Skip to main content
Clinical Trials/NCT04360512
NCT04360512
Terminated
Not Applicable

Dose-response of Posterior Talus Mobilizations on Ankle Range of Motion and Overall Mobility in Older Adults

University of Valencia1 site in 1 country42 target enrollmentMay 15, 2020
ConditionsAging Problems

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aging Problems
Sponsor
University of Valencia
Enrollment
42
Locations
1
Primary Endpoint
Treatment dose
Status
Terminated
Last Updated
5 years ago

Overview

Brief Summary

Ankle mobility limitations are common in older adults. A possible treatment to restore joint mobility is manual therapy based on mobilization techniques, in this case, applied on the ankle joint. Previous research had proposed different treatment volumes (one to twelve sessions), but shown a different and non-consistent degree of effectiveness according to such factor. Therefore, this work aims to determine the dose-response relationship of manual therapy (talus mobilizations) on ankle range of motion in the older adult. Secondarily, this research will appraise whether a likely improvement in ankle mobility may have an impact on the overall mobility (i.e. gait, get up from a chair).

Registry
clinicaltrials.gov
Start Date
May 15, 2020
End Date
September 14, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

David Hernández

PT, PhD

University of Valencia

Eligibility Criteria

Inclusion Criteria

  • Community-dwelling older adults
  • Over 60 years
  • Limited ankle dorsiflexion range of motion

Exclusion Criteria

  • Not willing to participate or signing a consent form
  • Lower limb injury in the three months prior to the study (ex. sprain)
  • Diagnosed condition that may influence mobility assessments (i.e. stroke)

Outcomes

Primary Outcomes

Treatment dose

Time Frame: Change from baseline to end of intervention (2 weeks)

Number of sessions of experimental intervention needed to induce a clinically important gain in ankle mobility after the intervention. A baseline progression over 4.6º in the Lunge test will be considered clinically important (Powden, 2015), so that the number of sessions will be established when this threshold is exceeded (see secondary outcome) .

Secondary Outcomes

  • Active ankle range of motion(Change from baseline, to end of intervention (2 weeks) and follow-up (10 weeks))
  • The Lunge test(Change from baseline, to end of intervention (2 weeks) and follow-up (10 weeks))
  • Timed up and go test (TUG)(Change from baseline, to end of intervention (2 weeks) and follow-up (10 weeks))

Study Sites (1)

Loading locations...

Similar Trials